Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Pickles

Showing results (11-20 of 139) with videos related to

Pageof 14
Sort By:
Cancer|March 15, 2008
Pretreatment prostate-specific antigen velocity is associated with development of distant metastases and prostate cancer mortality in men treated with radiotherapy and androgen-deprivation therapyDavid Palma, Scott Tyldesley, Tom Pickles, et al.
The Canadian Journal of Urology|July 18, 2002
The changing face of prostate cancer in British Columbia 1988-2000Tom Pickles, Andy Coldman, Norm Phillips
BJU International|July 10, 2007
Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancerDavid Palma, Tom Pickles, Scott Tyldesley, et al.
The Canadian Journal of Urology|May 10, 2005
Technology review: high-intensity focused ultrasound for prostate cancerTom Pickles, Larry Goldenberg, Gary Steinhoff
International Journal of Radiation Oncology, Biology, Physics|June 2, 2012
Impact of neoadjuvant prostate-specific antigen kinetics on biochemical failure and prostate cancer mortality: results from a prospective patient databaseMarcus Foo, Mariel Lavieri, Tom Pickles
The Journal of Urology|August 13, 2003
Asian race and impact on outcomes after radical radiotherapy for localized prostate cancerAda Man, Tom Pickles, Kim N Chi, et al.
International Journal of Radiation Oncology, Biology, Physics|July 3, 2009
Brachytherapy or conformal external radiotherapy for prostate cancer: a single-institution matched-pair analysisTom Pickles, Mira Keyes, W James Morris
Brachytherapy|September 25, 2018
Using a surgical prostate-specific antigen threshold of >0.2 ng/mL to define biochemical failure for intermediate- and high-risk prostate cancer patients treated with definitive radiation therapy in the ASCENDE-RT randomized control trialW James Morris, Tom Pickles, Mira Keyes
Brachytherapy|October 17, 2017
High-intermediate prostate cancer treated with low-dose-rate brachytherapy with or without androgen deprivation therapyTom Pickles, W James Morris, Mira Keyes
International Journal of Radiation Oncology, Biology, Physics|April 27, 2005
PSA doubling time kinetics during prostate cancer biochemical relapse after external beam radiation therapyAndrew Tom Bates, Tom Pickles, Chuck Paltiel
Pageof 14

Showing results (11-20 of 139) with videos related to

Sort By:
Pageof 14
Cancer|March 15, 2008
Pretreatment prostate-specific antigen velocity is associated with development of distant metastases and prostate cancer mortality in men treated with radiotherapy and androgen-deprivation therapyDavid Palma, Scott Tyldesley, Tom Pickles, et al.
The Canadian Journal of Urology|July 18, 2002
The changing face of prostate cancer in British Columbia 1988-2000Tom Pickles, Andy Coldman, Norm Phillips
BJU International|July 10, 2007
Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancerDavid Palma, Tom Pickles, Scott Tyldesley, et al.
The Canadian Journal of Urology|May 10, 2005
Technology review: high-intensity focused ultrasound for prostate cancerTom Pickles, Larry Goldenberg, Gary Steinhoff
International Journal of Radiation Oncology, Biology, Physics|June 2, 2012
Impact of neoadjuvant prostate-specific antigen kinetics on biochemical failure and prostate cancer mortality: results from a prospective patient databaseMarcus Foo, Mariel Lavieri, Tom Pickles
The Journal of Urology|August 13, 2003
Asian race and impact on outcomes after radical radiotherapy for localized prostate cancerAda Man, Tom Pickles, Kim N Chi, et al.
International Journal of Radiation Oncology, Biology, Physics|July 3, 2009
Brachytherapy or conformal external radiotherapy for prostate cancer: a single-institution matched-pair analysisTom Pickles, Mira Keyes, W James Morris
Brachytherapy|September 25, 2018
Using a surgical prostate-specific antigen threshold of >0.2 ng/mL to define biochemical failure for intermediate- and high-risk prostate cancer patients treated with definitive radiation therapy in the ASCENDE-RT randomized control trialW James Morris, Tom Pickles, Mira Keyes
Brachytherapy|October 17, 2017
High-intermediate prostate cancer treated with low-dose-rate brachytherapy with or without androgen deprivation therapyTom Pickles, W James Morris, Mira Keyes
International Journal of Radiation Oncology, Biology, Physics|April 27, 2005
PSA doubling time kinetics during prostate cancer biochemical relapse after external beam radiation therapyAndrew Tom Bates, Tom Pickles, Chuck Paltiel
Pageof 14